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background:  We have reported cytochrome P450 (CYP) 2C19 loss-of-function polymorphism was associated with reduced 
responsiveness to clopidogrel and poor clinical outcome after first-generation drug-eluting stent (DES) implantation. However, its 
contribution to lesion outcome after everolimus-eluting stent (EES) implantation remains unclear.
methods:  A total of 124 patients (185 lesions) who underwent EES implantation and follow-up optical coherence tomography (OCT) at 8 
months were enrolled. Patients were divided into extensive metabolizers (EM), intermediate metabolizers (IM) and poor metabolizers (PM) 
by CYP2C19 polymorphism and responsiveness to clopidogrel was assessed by measuring VerifyNow platelet reactivity unit (PRU) at 8 
months. OCT findings and one-year target lesion revascularization (TLR) were compared among EM, IM and PM.
results:  PRU significantly increased across the patients with EM, IM and PM (EM 183.4±63.1 vs. IM 215.5±64.9 vs. PM 261.7±82.8, 
p=0.001). The frequency of intra-stent thrombus showed a pattern to increase across the patients with EM, IM and PM (EM 8% vs. IM 12% 
vs. PM 19%, p=0.31). The incidence of TLR, however, was not different among the groups in this small cohort (EM 6.5%, IM 2.1% and PM 
7.7%, P=0.287).
Conclusion:  Although significant difference in platelet reactivity and stepwise pattern of intra-stent thrombus, the impact of CYP2C19 
polymorphism on lesion outcome is not obvious in patient treated with EES.
